在美国已经不再用Gefitinib（Iressa)了。

FDA ALERT [6/2005]

FDA has approved new labeling for Iressa that states the medicine should be used only in cancer patients who have already taken the medicine and whose doctor believes it is helping them. New patients should not be given Iressa because in a large study Iressa did not make people live longer. There are other medicines for non-small cell lung cancer (NSCLC) that have shown an ability to make people live longer.

http://www.fda.gov/cder/drug/infopage/gefitinib/default.htm

所有跟帖： 

• 她实际是原发的囊装腺性癌，在气管上，手术后五年坚持治疗 -九制话梅- ♀ (275 bytes) () 02/13/2006 postreply 08:43:11

• 回复：她实际是原发的囊装腺性癌，在气管上，手术后五年坚持治疗 -popcorn2006- ♀ (132 bytes) () 02/13/2006 postreply 11:16:09

• 好的谢谢你，只是除了上他们的网站，还能怎么打听呢？ -九制话梅- ♀ (0 bytes) () 02/14/2006 postreply 01:47:59